Clinical Briefing:
Transcranial Magnetic Stimulation (TMS)
for Treatment-Resistant Depression
September/October 2008
At the Penn Comprehensive Depression Center, an office-based
investigational procedure has shown significant promise for
the treatment of major depression in patients for whom psychotherapy
and antidepressant medications have not been effective.
Called
transcranial magnetic stimulation, or TMS, the treatment
involves placing an insulated coil on the scalp surface that
issues brief electromagnetic pulses to stimulate neurons
in the cerebral cortex. TMS treatments are administered in
an outpatient setting under the supervision of a licensed
MD, usually a psychiatrist. A full course of treatments can
range from 15 to 30 sessions, with sessions typically conducted
five days per week over a three – four week period.
When an acute course of TMS has been effective, long term
maintenance treatment sessions are usually administered about
twice per month.1
“In
addition to a milder side effect profile, in
general, compared to antidepressants and ECT,
transcranial magnetic stimulation offers the
potential for gratifying outcomes for patients
with treatment-resistant major depression,” said John
P. O'Reardon, MD. |
|
Although the mechanism of action of TMS in depression
has yet to be fully elucidated, reports emanating from Penn
and other research centers support its use as a therapeutic
intervention in mood and anxiety disorders.2 In a recent,
large, multicenter clinical trial of TMS in major depression,
patients treated with TMS therapy had an almost twofold higher
remission rate at six weeks compared to patients in the control
group.3

During transcranial magnetic
stimulation (TMS), an insulated magnetic
coil placed on the scalp surface issues brief
electromagnetic pulses to stimulate neurons
in the cerebral cortex.
|
|
The side effects of TMS are mild and transitory,
and may include mild headache or scalp discomfort at the
site of stimulation.4 In contrast to electroconvulsive therapy
(ECT), the standard treatment for refractory depression,
no significant cognitive adverse effects (including memory
impairments) are associated with TMS. Moreover, because TMS
is a non-systemic device treatment, it avoids problems like
weight gain, sedation and sexual dysfunction that can be
problematic with medications.
Case Study
Mrs. K, a 43-year-old woman, came to Penn's Comprehensive
Depression Center for a second opinion when her psychiatrist
recommended consideration of electroconvulsive therapy for
the treatment of her severe depression. At presentation,
Mrs. K reported low mood, anhedonia, hopelessness, insomnia,
weight loss and low energy, as well as significant impairment
in her daily functioning. Mrs. K, a full-time teacher and
mother of two young children, was finding it extremely
difficult to keep up with her work and home responsibilities.
This
was the third episode of major depression in her lifetime
and adequate trials of antidepressants and a course of psychotherapy
had failed to relieve her depression on this occasion. Following
a careful weighing of her options, Mrs. K elected to pursue
TMS as an off-label treatment for her depression at Penn.
After
20 sessions of TMS over four weeks, her depression responded.
TMS was well tolerated with the only side effect being mild
scalp discomfort during the first week of treatment. TMS
was tapered to a session frequency of twice per month, which
was continued as maintenance treatment for the next 6 months.
Mrs. K made a successful return to work and was gratified
to find that her cognitive functioning was as sharp as before.
She now takes an antidepressant as prophylaxis against recurrence
and is reassured by the knowledge that TMS is available to
her as an option should she need further treatments in the
future.
Our Team of Faculty
Comprised of psychiatrists, psychologists and dedicated support
personnel, Penn Psychiatry's Comprehensive Depression Center
specializes in the study of the causes of depression and
anxiety, and treatments for these conditions.
The TMS Treatment Team
John P. O'Reardon, MD
Associate Professor of Psychiatry
Michael E. Thase, MD
Professor of Psychiatry
Deborah Kim, MD
Assistant Professor of Psychiatry
Pilar Cristancho, MD
Instructor, Fellow in Mood Disorders and Neuromodulation
For
further information about transcranial magnetic stimulation,
visit www.med.upenn.edu/tms.
Access
Department of Psychiatry
Penn Behavioral Health
3535 Market Street
Philadelphia, PA 19104
1.866.301.4PBH (4724)
To refer a patient and/or consult
with a doctor about TMS, call 215.573.8582 or
visit www.med.upenn.edu/tms/contact.
References
- O'Reardon JP, Blumner KH, Peshek A, et al. Long-term
maintenance therapy for major depression with left prefrontal
repetitive transcranial magnetic stimulation (rTMS).
J Clin Psychiat. 2005;66:1524-1528.
- O'Reardon JP,
Solvason HB, Janicak PG, et al. Efficacy and safety of
Transcranial Magnetic Stimulation in the acute treatment
of major depression: a multi-site randomized controlled
trial. Biol Psychiat. 2007;62:1208-16.
- Janicak PG, O'Reardon
JP, Sampson SM, et al. Transcranial Magnetic Stimulation
(TMS) in the treatment of major depression: A comprehensive
summary of safety experience from acute exposure, extended
exposure and during reintroduction treatment.
J Clin Psychiat. 2008;69:222-232.
- Lisanby, SH, Kinnunen
LH, Crupain MJ. Applications of TMS to therapy in psychiatry. J
Clin Neurophysiol. 2002;19:344-60.
|

|
Referring Physicians: To speak with a Penn physician
or refer a patient, contact PennHealth through the secure online
referral form or by calling
1-800-789-PENN
(7366). |
 |
 |
 |
|